{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:49:34Z","timestamp":1761238174642,"version":"build-2065373602"},"reference-count":178,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Medicine"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/17460751.2025.2571360","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T06:24:31Z","timestamp":1759818271000},"page":"509-526","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["One down but many more to go: the state of gene therapy for inherited retinal disease"],"prefix":"10.1080","volume":"20","author":[{"given":"Tien-En","family":"Tan","sequence":"first","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]},{"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, UK"]},{"name":"University of Oxford","place":["Oxford, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Z.Y.","family":"Sun","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley S.J.","family":"Poh","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Lim","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin X.J.","family":"Teo","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Dey","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary W.X.","family":"Chua","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxun","family":"Wang","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwee Goon","family":"Tay","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-7604","authenticated-orcid":false,"given":"Beau J.","family":"Fenner","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre","place":["Singapore, Singapore"]},{"name":"Singapore Eye Research Institute","place":["Singapore, Singapore"]},{"name":"Duke-NUS Graduate Medical School","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.04.008"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.04.008"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004015"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/13816810.2021.1913610"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319365"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/819760"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.12.003"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-025-01833-w"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00874-6"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgad043"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes9070360"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24064"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802519115"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.02.004"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108330"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.013"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2022.05.001"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1092-93"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.175.4025.949"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31868-8"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.03.031"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14010122"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03637-0"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1515\/medgen-2024-2067"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-02036-7"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02520-3"},{"key":"e_1_3_5_29_1","unstructured":"Proqr announces top-line results from phase 2\/3 illuminate trial of sepofarsen in CEP290-mediated LCA10 | ProQR Therapeutics [Internet]. [cited 2025 Apr 14]. Available from: https:\/\/www.proqr.com\/press-releases\/proqr-announces-top-line-results-from-phase-23-illuminate-trial-of-sepofarsen-in-cep290-mediated-lca10"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/13816810802626399"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-139"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-194"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/3813"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-0556-2-3"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0501-92"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2003.11.013"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2006.03.005"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2006.17.845"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802268"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802315"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0807027105"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05508-2"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.09.006"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2024-326221"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2021.03.016"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.02.015"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101484"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.2.13"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-76550-6_17"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500646102"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.19-26672"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.043"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01327-07"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.179"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.66"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.1032"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0218-122"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.09.2841"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.2512"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.9.17"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01243-y"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08211-y"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01003-y"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.12.6.4"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.9.18"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.10.15"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.16780"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.12.039"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.14.36"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100595"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002808"},{"key":"e_1_3_5_74_1","unstructured":"J&j gene therapy treatment fails primary endpoints [internet]. Ophthalmology Times. 2025 [cited 2025 May 17]. Available from: https:\/\/www.ophthalmologytimes.com\/view\/j-j-gene-therapy-treatment-fails-primary-endpoints"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.05.024"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.7.12"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.4160"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.0502"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4945"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.6.56"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.794805"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.255"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2014.08.001"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2010.122"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2022.899260"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-024-03679-1"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100915"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22494"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1159\/000540607"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2022.2152715"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000537818"},{"key":"e_1_3_5_92_1","first-page":"588","article-title":"Genotypes and phenotypes of genes associated with achromatopsia: a reference for clinical genetic testing","volume":"26","author":"Sun W","year":"2020","unstructured":"Sun W, Li S, Xiao X, et al. Genotypes and phenotypes of genes associated with achromatopsia: a reference for clinical genetic testing. Mol Vis. 2020;26:588\u2013602.","journal-title":"Mol Vis"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2023.05.009"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01806-3"},{"key":"e_1_3_5_95_1","unstructured":"4D Molecular Therapeutics. Phase 1 open-label dose-escalation study of the safety tolerability and preliminary efficacy of intravitreal 4D-110 in patients with choroideremia [Internet]. clinicaltrials.gov; Report no.: NCT04483440. Available from 2024 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04483440"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01447-8"},{"key":"e_1_3_5_97_1","unstructured":"Opus genetics announces presentation of OPGX-LCA5 gene therapy data at ARVO; 12 month phase 1\/2 results support potential to restore to meaningful vision [Internet]. Opus genetics Inc. 2025 [cited 2025 May 18]. Available from: https:\/\/ir.opusgtx.com\/press-releases\/detail\/484\/opus-genetics-announces-presentation-of-opgx-lca5-gene-therapy-data-at-arvo-12-month-phase-12-results-support-potential-to-restore-to-meaningful-vision?utm_source=chatgpt.com"},{"key":"e_1_3_5_98_1","unstructured":"Arvo 2025\u00a0highlight: j&J\u2019s XLRP gene therapy didn\u2019t meet primary endpoint in phase 3 clinical trial [Internet]. Foundation fighting blindness. [cited 2025 May 18Available from: https:\/\/www.fightingblindness.org\/news\/arvo-2025-highlight-j-j-s-xlrp-gene-therapy-didn-t-meet-primary-endpoint-in-phase-3-clinical-trial-2290"},{"key":"e_1_3_5_99_1","unstructured":"4D Molecular Therapeutics. An open-label phase 1\/2 trial of gene therapy 4D-125 in males with X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene [Internet]. clinicaltrials.gov; Report no.: NCT04517149. Available from 2025 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04517149"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.02.023"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2024.11.021"},{"key":"e_1_3_5_102_1","unstructured":"STZ eyetrial. Pigment - PDE6A gene therapy for retinitis pigmentosa [Internet]. clinicaltrials.gov; Report no.: NCT04611503. Available from 2024 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04611503"},{"key":"e_1_3_5_103_1","unstructured":"eyeDNA Therapeutics. Safety and efficacy of a unilateral subretinal administration of HORA-PDE6B in patients with retinitis pigmentosa harbouring mutations in the PDE6B gene leading to a defect in PDE6\u00df expression [Internet]. clinicaltrials.gov; Report no.: NCT03328130. Available from 2024 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03328130"},{"key":"e_1_3_5_104_1","unstructured":"Splice Bio. A phase 1\/2 first-in-human open-label assessor-masked randomized controlled dose escalation\/expansion study to evaluate the safety tolerability and preliminary efficacy of a subretinal injection of SB-007 in subjects with Stargardt disease (STGD1) caused by bi-allelic autosomal recessive mutations in the ATP binding cassette subfamily A member 4 (ABCA4) gene. [Internet]. clinicaltrials.gov; Report no.: NCT06942572. Available from 2025 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06942572"},{"key":"e_1_3_5_105_1","unstructured":"Vigeneron -Vigeneron announces FDA clearance of IND for novel mRNA trans-splicing gene therapy VG801 to treat Stargardt disease and other ABCA4-linked retinal dystrophiesvigeneron [Internet]. [cited 2025 May 18]. Available from: https:\/\/vigeneron.com\/press\/vigeneron-announces-fda-clearance-of-ind-for-novel-mrna-trans-splicing-gene-therapy-vg801-to-treat-stargardt-disease-and-other-abca4-linked-retinal-dystrophies\/?utm_source=chatgpt.com"},{"key":"e_1_3_5_106_1","unstructured":"Atsena therapeutics completes dosing in part a of phase I\/II clinical trial evaluating ATSN-201 to treat X-linked retinoschisis [Internet]. Ophthalmology Times. 2024 [cited 2025 May 17]. Available from: https:\/\/www.ophthalmologytimes.com\/view\/atsena-therapeutics-completes-dosing-in-part-a-of-phase-i-ii-clinical-trial-evaluating-atsn-201-to-treat-x-linked-retinoschisis"},{"key":"e_1_3_5_107_1","unstructured":"AAVantgarde Bio Srl. A phase 1\/2 multicenter open-label dose escalation safety and efficacy study of subretinal administration of dual AAV8.MYO7A AAVB-081 in subjects with Usher syndrome type IB (USH1B) retinitis pigmentosa [Internet]. clinicaltrials.gov; Report no.: nct06591793. Available from 2025 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06591793"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179739"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319067"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1177\/2515841418817490"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316028"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100397"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002360"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0185-5"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1086\/507318"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy179"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309915"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01755-w"},{"key":"e_1_3_5_119_1","unstructured":"Proqr announces top-line results from phase 2\/3 illuminate trial of sepofarsen in CEP290-mediated LCA10 | ProQR Therapeutics [Internet]. [cited 2025 May 17]. Available from: https:\/\/www.proqr.com\/press-releases\/proqr-announces-top-line-results-from-phase-23-illuminate-trial-of-sepofarsen-in-cep290-mediated-lca10"},{"key":"e_1_3_5_120_1","unstructured":"Opus Genetics announces updates on OPGx-LCA5 clinical program [Internet]. Opus genetics Inc. 2025 [cited 2025 May 17]. Available from: https:\/\/ir.opusgtx.com\/press-releases\/detail\/474\/opus-genetics-announces-updates-on-opgx-lca5-clinical-program"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003920"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S365486"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2022.205"},{"key":"e_1_3_5_124_1","unstructured":"Sepul bio is developing ultevursen for USH2A [Internet]. [cited 2025 May 17]. Available from: https:\/\/www.usher-syndrome.org\/research\/industry\/sepul-bio.html\/article\/2024\/12\/12\/first-participant-dosed-in-phase-2b-clinical-trial-of-ultevursen-for-ush2a-associated-rp"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041288"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.06.013"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.05.025"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2564-5"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2024.124"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101309"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237385"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56738-5"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00503"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav4523"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7522-8_11"},{"key":"e_1_3_5_136_1","unstructured":"First patient dosed in phase 1\/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio) [Internet]. Ophthalmology Times. 2025 [cited 2025 May 17]. Available from: https:\/\/europe.ophthalmologytimes.com\/view\/first-patient-dosed-in-phase-1-2-astra-study-for-stargardt-disease-therapy-sb-007-splicebio-"},{"key":"e_1_3_5_137_1","unstructured":"Aavantgarde Bio\u2019s dual-vector USH1B gene therapy moves into phase 1\/2 clinical trial [Internet]. Foundation Fighting Blindness. [cited 2025 May 17]. Available from: https:\/\/www.fightingblindness.org\/news\/aavantgarde-bio-s-dual-vector-ush1b-gene-therapy-moves-into-phase-1-2-clinical-trial-1135"},{"key":"e_1_3_5_138_1","unstructured":"Aavantgarde presents safety data of the LUCE-1 study of AAVB-081 for RP related to Usher 1B [Internet]. AAVantgarde. 2024 [cited 2025 May 17]. Available from: https:\/\/www.aavantgarde.com\/en\/news\/aavantgarde-presents-safety-data-of-the-luce-1-study-of-aavb-081-for-rp-related-to-usher-1b\/"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.06.030"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.7.7"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42189-3"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4623"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.306063"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171356"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.09.010"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0327-9"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1210"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-020-00632-6"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29490-3"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00788-9"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.220"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.001"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx438"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.01.006"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107638"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2416827121"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00258-6"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-022-00352-3"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav3335"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.02.011"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220776"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03422-8"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225829"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1208507109"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.07.009"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1210"},{"key":"e_1_3_5_167_1","unstructured":"Peking University Third Hospital. A single-arm open-label exploratory clinical study to assess the preliminary safety of the gene editing drug ZVS203e for the management of retinitis pigmentosa caused by mutations in the RHO gene. [Internet]. clinicaltrials.gov; Report no.: NCT05805007. Available from 2023 [cited 2025 May 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05805007"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17946"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1711-4"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.6418"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002071"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2023.03.004"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01351-4"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-vision-111815-114425"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.03.001"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.20.2701"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1189369"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11019-016-9741-2"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1353\/hcr.0.0103"},{"key":"e_1_3_5_180_1","volume-title":"Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Conflict of interest in medical research, education, and practice.","author":"Lo B","year":"2009","unstructured":"]. Lo B, Field MJ, editors. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Conflict of interest in medical research, education, and practice. [Internet]. (WA) (DC): National Academies Press (US); 2009 [cited 2025 May 18]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK22942\/"}],"container-title":["Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460751.2025.2571360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:45:01Z","timestamp":1761237901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460751.2025.2571360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":178,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/17460751.2025.2571360"],"URL":"https:\/\/doi.org\/10.1080\/17460751.2025.2571360","relation":{},"ISSN":["1746-0751","1746-076X"],"issn-type":[{"type":"print","value":"1746-0751"},{"type":"electronic","value":"1746-076X"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}